American Growth Cannabis E
Name
As of 11/15/2022Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
385.7%
1 yr return
-89.4%
3 Yr Avg Return
-53.0%
5 Yr Avg Return
-38.0%
Net Assets
$251 K
Holdings in Top 10
66.4%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 6.02%
SALES FEES
Front Load 5.75%
Deferred Load N/A
TRADING FEES
Turnover 461.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$0
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 11/15/2022Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
AMREX - Profile
Distributions
- YTD Total Return 385.7%
- 3 Yr Annualized Total Return -53.0%
- 5 Yr Annualized Total Return -38.0%
- Capital Gain Distribution Frequency N/A
- Net Income Ratio -5.42%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameAmerican Growth Cannabis Fund
-
Fund Family NameAmerican Growth
-
Inception DateFeb 24, 2011
-
Shares OutstandingN/A
-
Share ClassOther
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerTimothy Taggart
Fund Description
* | Pharmaceutical companies primarily engaged in the research, development, marketing and/or distribution of cannabis related drugs. |
* | Botanical Medical Chemical companies primarily engaged in manufacturing cannabis bulk organic and inorganic medicinal chemicals and their derivatives and processing (grading, grinding, and milling) bulk botanical drugs. |
* | Biotechnology companies engaged in the exploitation of cannabis biological processes for industrial and other purposes, especially the genetic manipulation of microorganisms for the production of antibiotics, hormones, etc. |
“Hemp” refers to cannabis plants with a delta-9 tetrahydrocannabinol ("THC") concentration of not more than 0.3 percent on a dry weight basis, as well as derivatives thereof, whereas "marijuana" refers to all other cannabis plants and derivatives thereof. Hemp can be grown as a renewable source for raw materials that can be incorporated into thousands of products. Its seeds and flowers are used in health foods, organic body care, and other nutraceuticals. The fibers and stalks are used in hemp clothing, construction materials, paper, biofuel, plastic composites, and more. Many CBD oil products are extracted from hemp, rather than other members of the cannabis family, as CBD dominates the plant’s makeup. The Fund’s equity investments will consist only of exchange traded equity securities of companies that are engaged in legal activities under applicable national and local laws, including U.S. federal and state laws. The Fund will not invest in companies that violate anti-money laundering as defined by various laws. The Fund will only invest in companies that list their securities on exchanges that require the companies’ compliance with all laws, rules and regulations applicable to their business, including U.S. federal and state laws. These companies may be domestic or foreign entities and are engaged in the legal cannabis and hemp business under national and local laws, including U.S. federal and state law, as applicable. The Fund may have exposure to emerging market issuers. In addition to the principal investment strategy, the Fund may also invest in securities convertible into common stock in companies involved in the legal cannabis and hemp business. These securities may be issued by large companies and also small and mid-sized companies, micro-cap companies as well as REITs. Income through dividend payments is a secondary objective. Income also becomes a Fund objective when it is in a temporary, defensive position. The Fund may invest in securities of other investment companies, including exchange-traded funds, to obtain desired exposures. The Fund may engage in active and frequent trading of portfolio securities to achieve its principal investment strategies. There are several reasons that could cause the Advisor to sell all, or a portion of, a position of the Fund’s portfolio holdings. These reasons include, in the Advisor’s opinion, one or more of the following occurs: (i) the company no longer meets the investment criteria defined above; (ii) a particular security has achieved the Advisor’s investment expectations; (iii) the reason(s) for maintaining the position are no longer valid; (iv) the Advisor’s view of the business fundamentals or management of the underlying company changes; (v) a more attractive investment opportunity is found; (vi) general market conditions trigger a change in the Advisor’s assessment criteria; (vii) for other portfolio management reasons; or (viii) the Fund requires cash to meet redemption requests.
AMREX - Performance
Return Ranking - Trailing
Period | AMREX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 385.7% | -58.2% | 572.7% | 0.33% |
1 Yr | -89.4% | -89.4% | 510.3% | 100.00% |
3 Yr | -53.0%* | -53.0% | 33.6% | 100.00% |
5 Yr | -38.0%* | -38.0% | 24.3% | 100.00% |
10 Yr | -27.9%* | -27.9% | 19.6% | 100.00% |
* Annualized
Return Ranking - Calendar
Period | AMREX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -98.2% | -98.2% | 781.7% | 100.00% |
2022 | 9.1% | -39.1% | 109.8% | 82.21% |
2021 | -3.1% | -3.1% | 36.5% | 100.00% |
2020 | -6.8% | -29.8% | 7.4% | 74.22% |
2019 | -1.2% | -8.2% | 29.5% | 95.75% |
Total Return Ranking - Trailing
Period | AMREX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 385.7% | -67.4% | 572.7% | 0.33% |
1 Yr | -89.4% | -89.4% | 510.3% | 100.00% |
3 Yr | -53.0%* | -53.0% | 33.6% | 100.00% |
5 Yr | -38.0%* | -38.0% | 24.3% | 100.00% |
10 Yr | -27.9%* | -27.9% | 19.6% | 100.00% |
* Annualized
Total Return Ranking - Calendar
Period | AMREX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -98.2% | -98.2% | 781.7% | 100.00% |
2022 | 9.1% | -39.1% | 109.8% | 82.21% |
2021 | -3.1% | -3.1% | 36.5% | 100.00% |
2020 | -6.8% | -29.8% | 8.5% | 81.03% |
2019 | -1.2% | -1.7% | 40.9% | 99.39% |
NAV & Total Return History
AMREX - Holdings
Concentration Analysis
AMREX | Category Low | Category High | AMREX % Rank | |
---|---|---|---|---|
Net Assets | 251 K | 183 K | 28 B | 99.84% |
Number of Holdings | 19 | 6 | 1336 | 98.08% |
Net Assets in Top 10 | 211 K | 59 K | 2.7 B | 99.68% |
Weighting of Top 10 | 66.38% | 4.7% | 100.0% | 2.41% |
Top 10 Holdings
- The Valens Co Inc Ordinary Shares 10.84%
- Innovative Industrial Properties Inc Registered Shs 10.52%
- Power REIT 10.21%
- The Valens Co Inc Ordinary Shares 8.72%
- Vestas Wind Systems A/S Adr 8.10%
- Lifeist Wellness Inc 8.00%
- Abbott Laboratories 7.32%
- Teladoc Health Inc 6.21%
- Tennessee Valley Auth 6.04%
- GrowGeneration Corp 6.00%
Asset Allocation
Weighting | Return Low | Return High | AMREX % Rank | |
---|---|---|---|---|
Stocks | 78.36% | 77.52% | 101.30% | 99.68% |
Other | 20.21% | -1.57% | 20.21% | 0.16% |
Cash | 1.43% | -1.30% | 22.49% | 63.62% |
Preferred Stocks | 0.00% | 0.00% | 3.43% | 45.99% |
Convertible Bonds | 0.00% | 0.00% | 1.57% | 44.23% |
Bonds | 0.00% | 0.00% | 3.19% | 43.91% |
Stock Sector Breakdown
Weighting | Return Low | Return High | AMREX % Rank | |
---|---|---|---|---|
Healthcare | 58.05% | 0.00% | 58.05% | 0.16% |
Real Estate | 27.01% | 0.00% | 27.01% | 0.16% |
Consumer Cyclical | 13.06% | 0.00% | 40.68% | 41.19% |
Consumer Defense | 1.20% | 0.00% | 13.56% | 90.71% |
Technology | 0.44% | 0.00% | 75.51% | 99.52% |
Industrials | 0.25% | 0.00% | 36.64% | 98.88% |
Utilities | 0.00% | 0.00% | 5.57% | 60.10% |
Financial Services | 0.00% | 0.00% | 100.00% | 99.20% |
Energy | 0.00% | 0.00% | 55.49% | 84.13% |
Communication Services | 0.00% | 0.00% | 15.31% | 90.71% |
Basic Materials | 0.00% | 0.00% | 10.30% | 89.58% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | AMREX % Rank | |
---|---|---|---|---|
Non US | 46.32% | 0.00% | 46.32% | 0.16% |
US | 32.04% | 32.04% | 99.56% | 100.00% |
AMREX - Expenses
Operational Fees
AMREX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 6.02% | 0.03% | 6.02% | 0.16% |
Management Fee | 1.00% | 0.05% | 4.05% | 87.16% |
12b-1 Fee | 0.30% | 0.00% | 1.00% | 66.29% |
Administrative Fee | N/A | 0.01% | 0.40% | N/A |
Sales Fees
AMREX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | 5.75% | 3.50% | 5.75% | 21.79% |
Deferred Load | N/A | 1.00% | 5.50% | N/A |
Trading Fees
AMREX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
AMREX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 461.00% | 3.00% | 461.00% | 100.00% |
AMREX - Distributions
Dividend Yield Analysis
AMREX | Category Low | Category High | AMREX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 23.81% | 46.45% |
Dividend Distribution Analysis
AMREX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annually | Annually | Quarterly | Annually |
Net Income Ratio Analysis
AMREX | Category Low | Category High | AMREX % Rank | |
---|---|---|---|---|
Net Income Ratio | -5.42% | -5.42% | 1.10% | 100.00% |
Capital Gain Distribution Analysis
AMREX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Sep 30, 2020 | $0.035 | OrdinaryDividend |
Sep 01, 2020 | $0.035 | OrdinaryDividend |
Aug 01, 2020 | $0.039 | OrdinaryDividend |
AMREX - Fund Manager Analysis
Managers
Timothy Taggart
Start Date
Tenure
Tenure Rank
Apr 30, 2011
11.09
11.1%
Timothy Taggart has been a member of the Investment Committee since September of 2010 and is the President of World Capital Brokerage, Inc. For the years prior to April 12, 2011, Mr. Taggart served on the Board of Directors for IRC, as Treasurer and Chief Compliance officer as well as on the Board of Directors for WCB as President and Chief Compliance Office.
Robert Fleck
Start Date
Tenure
Tenure Rank
Apr 30, 2011
11.09
11.1%
Robert Fleck, employee of Investment Research Corporation and Investment Committee member since September 2010. Mr. Fleck is owner of World Capital Advisors (“WCA”). For the years prior to April 12, 2011, Mr. Fleck served as President and CEO of World Capital Advisors, LLC., a registered Investment Advisor.
Matthew Taggart
Start Date
Tenure
Tenure Rank
Apr 30, 2021
1.08
1.1%
Mr. Matthew Taggart has been responsible for managing the Fund’s security portfolio through his positions with IRC, and the Fund’s Investment Advisory Committee. Mr. M. Taggart joined the advisor in July of 2013.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.08 | 30.44 | 8.96 | 5.25 |